✦ LIBER ✦
701 ‘Tomudex’ (ZD1694) has a higher response rate, significantly less leucopenia and mucositis and a simpler dosing regimen than 5-fluorouracil (5-FU) and leucovorin (LV) for advanced colorectal cancer (CRC): First results of a phase III study
✍ Scribed by F. Zalcberq; D. Cunningham; U. Rath; I. Olver; D. Kerr; E. Van Cutsem; C. Svenson; J.F. Seitz; P. Harper
- Book ID
- 116167448
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 163 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.